We have located links that may give you full text access.
Advanced oxidation of five contaminants in water by UV/TiO2: Reaction kinetics and byproducts identification.
Journal of Environmental Management 2016 October 2
The extent and kinetics of degradation of 1,4 dioxane, n-nitrosodimethylamine (NDMA), tris-2-chloroethyl phosphate (TCEP), gemfibrozil, and 17β estradiol in a prepared aqueous matrix by means of UV/TiO2 (ultraviolet light/titanium dioxide) oxidation was evaluated. Degussa P25 TiO2 was employed as a photocatalyst excited by UV light in a 1 L water-jacketed batch photoreactor. The rate of degradation was modeled using a pseudo-first order rate model and the Langmuir-Hinshelwood rate model with a high correlation. Degradation rate constants were found to be maximum at pH 5.0 and 1.5 g L(-)(1) TiO2 dose. For these conditions first order rate constants, values were as follows: 0.29 min(-1) for 1,4 dioxane, 0.50 min(-1) for NDMA, 0.12 min(-1) for TCEP, 0.61 min(-1) for gemfibrozil, and 0.53 min(-1) for 17β estradiol. While for the Langmuir-Hinshelwood rate model, the following constants were found: 0.11 Lmg(-1) and 2.81 mgL(-1) min(-1) for 1,4 dioxane, 0.12 Lmg(-1) and 4.35 mgL(-1) min(-1) for NDMA, 0.06 Lmg(-1) and 1.79 mgL(-1) min(-1) for TCEP, 0.21 Lmg(-1) and 3.27 mgL(-1) min(-1) for gemfibrozil, and 0.15 Lmg(-1) and 3.43 mgL(-1) min(-1) for 17β estradiol. In addition, specific byproducts of degradation were identified using GC/MS analysis. The results obtained from the kinetics analysis showed that UV/TiO2 oxidation is a promising process for treating trace organic contaminants in water, but further research is needed to better understand how to incorporate these findings into pilot and full-scale designs. The toxicity of oxidation byproducts, and their potential for interacting with other compounds should be considered in the treatment of contaminated waters using the UV/TiO2 oxidation process.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app